Results 81 to 90 of about 7,149 (178)

The developmental history of study on neuromyelitis optica

Chinese Journal of Contemporary Neurology and Neurosurgery, 2014
In 19th century, neuromyelitis optica (NMO) indicated optic neuritis and myelitis with simultaneous onset of both sides. Later studies proposed that the onset of right or left side optic neuritis could be separated by weeks, months even years.
Kai FENG, Xing-hu ZHANG, Xian-hao XU
doaj  

Association between FOXP3 polymorphisms and expression and neuromyelitis optica spectrum disorder risk in the Northern Chinese Han population

Translational Neuroscience
Forkhead box P3 (FOXP3) plays a critical role in the pathogenesis of autoimmune disorders. In the present study, we genotyped three single-nucleotide polymorphisms, namely, rs2232365, rs3761548, and rs3761549, to determine the relationship between FOXP3 ...
Liu Jing, Wang Gaoning, Yang Jiahe, Wang Yulin, Guo Ruoyi, Li Bin   +5 more
doaj   +1 more source

Research progress of neuromyelitis optica spectrum disorders: Chinese scholars' reports published abroad

Chinese Journal of Contemporary Neurology and Neurosurgery, 2016
Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of central nervous system (CNS), characterized by severe optic neuritis (ON) and transverse myelitis (TM). Since the discovery of NMO-immunoglobulin G (NMO-IgG), the definition of NMO
Jie-xi WEN, Hong-jun HAO, Feng GAO, Yi-ning HUANG   +3 more
doaj  

Neuromyelitis Optica Spectrum Disorders in Africa: A Systematic Review. [PDF]

Neurol Neuroimmunol Neuroinflamm
Musubire AK, Derdelinckx J, Reynders T, Meya DB, Bohjanen PR, Cras P, Willekens B.   +6 more
europepmc   +1 more source

Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disorders. [PDF]

Neurol Res Pract
Tkachenko D, Ayzenberg I, Schöppe LM, Schülke R, Paul F, Duchow A, Bellmann-Strobl J, Siebert N, Kümpfel T, Havla J, Pellkofer H, Jarius S, Wildemann B, Berthele A, Klotz L, Pawlitzki M, Gingele S, Schreiber-Katz O, Weber MS, Senel M, Stellmann JP, Häußler V, Aktas O, Ringelstein M, Hellwig K, Schwake C, Kleiter I, Trebst C, Hümmert MW, Neuromyelitis Optica Study Group (NEMOS)§.   +29 more
europepmc   +1 more source

Prognostic Biomarker Signature of Relapse in Neuromyelitis Optica Spectrum Disorders in the CIRCLES Observational Study. [PDF]

Neurol Neuroimmunol Neuroinflamm
Bach E, Breschi A, Wang Y, Carroll MK, Luk W, Han A, Short S, Cimermančič P, Drake KA, Cook LJ, Snyder T, Smith TJ, Yeaman MR, Kim CC, Guthy-Jackson Charitable Foundation CIRCLES Study Group.   +14 more
europepmc   +1 more source

Insufficient mycophenolate mofetil maintenance dosage increases the relapse risk in neuromyelitis optica spectrum disorders. [PDF]

Front Immunol
Zhou X, Du J, Duan Y, Shi C, Jia J, Gao H, Xiao X, Cao S, Xue Q.   +8 more
europepmc   +1 more source

Biomarkers for satralizumab treatment in neuromyelitis optica spectrum disorders: a prospective case series. [PDF]

BMC Neurol
Hu S, Wang X, Wu H, Hong R, Xiao X, Zhao Y, Li R.   +6 more
europepmc   +1 more source

HLA Associations Differ by Ethnicity and Aquaporin-4 Antibody Status in Patients With Neuromyelitis Optica Spectrum Disorders. [PDF]

Neurol Neuroimmunol Neuroinflamm
Niederschweiberer M, Panagiotaropoulou G, Fernandez-Viña MA, Montero-Martin G, Osoegawa K, Behne M, Franke A, Lieb W, Jarius S, Wildemann B, Schindler P, Otto C, Paul F, Flanagan EP, Cook LJ, Oksenberg J, Yeaman MR, Ripke S, Ruprecht K, Guthy-Jackson Charitable Foundation CIRCLES Study Group.   +19 more
europepmc   +1 more source

Real-World Multicenter Cohort Study of Inebilizumab vs Low-Dose Rituximab in Neuromyelitis Optica Spectrum Disorders. [PDF]

Neurol Neuroimmunol Neuroinflamm
Xu Q, Zhang L, Duan X, Zhou K, Li Z, Yang X, Wang J, Jiang J, Xu K, Yu G, Zheng P, Li Y, Qin X, Li J, Wang WY, Zhao H, Huang D, Qu H, Xiao H, Li B, Wu L, Feng J.   +21 more
europepmc   +1 more source